Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
3
×
san diego blog main
drugs
new york top stories
san diego top stories
san francisco blog main
akcea therapeutics
anylam pharmaceuticals
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
cardiomyopathy
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
duchenne muscular dystrophy
dyne therapeutics
entrectinib
express scripts
facioscapulohumeral muscular dystrophy
fda
foundation medicine
gene therapy
indiana blog main
indiana top stories
What
drug
3
×
genetic
3
×
ago
approved
fda
medicines
oks
rare
akcea
alnylam
amyloidosis
attr
available
battle
biotechs
cancer
considering
data
debilitating
deeper
disease
diseases
dna
dyne
early
expected
experimental
eyes
fingerprint
going
having
humans
ipo
ipos
long
matter
medicine
muscle
nd
new
Language
unset
Current search:
drug
×
" new york blog main "
×
genetic
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues